0DL.F BIOSYNEX INH. EO-10

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
0.8020 EUR
Close of Nov 11, 2026
0.4630 1.61
Market cap
EUR 14.8M
P/E
-
P/B
0.41x
ROE
-166.6%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 0DL.F undervalued?

Graham number

The Graham number of BIOSYNEX INH. EO-10 cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

BIOSYNEX INH. EO-10 fundamental analysis

No fundamental analysis for BIOSYNEX INH. EO-10 yet.

BIOSYNEX INH. EO-10 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About BIOSYNEX INH. EO-10

Biosynex SA designs, manufactures, and distributes rapid diagnostic tests to patients and healthcare professionals in France and internationally. The company develops and markets IVDs in the form of RDTs and TRODs, immunoblot, molecular biology, and POC for screening, diagnosis, and prevention. It also provides thermometers, tensiometers, oximetry, hearing protection products, oral and dental hygiene products, self-tests, thermal pads, inhalation chambers, and thermotherapy …

Full company profile